Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DR by Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DR

Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

62 pages • missing pub info (view editions)

nonfiction health challenging informative medium-paced
Powered by AI (Beta)
Loading...

Description

Hypertension is the most common reason older adults visit the doctor and advances in antihypertensive therapy have dramatically reduced the associated cardiovascular, cerebrovascular, and renal events. Inhibitors of the renin-angiotensin system (R...

Read more

Community Reviews

Loading...

Content Warnings

Loading...